181 related articles for article (PubMed ID: 12118398)
21. Hepatitis C infection and the patient with end-stage renal disease.
Fabrizi F; Poordad FF; Martin P
Hepatology; 2002 Jul; 36(1):3-10. PubMed ID: 12085342
[TBL] [Abstract][Full Text] [Related]
22. KDOQI US Commentary on the 2018 KDIGO Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C.
Roth D; Bloom RD; Molnar MZ; Reese PP; Sawinski D; Sise ME; Terrault NA
Am J Kidney Dis; 2020 May; 75(5):665-683. PubMed ID: 32279907
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis C virus in chronic dialysis patients.
Natov SN; Pereira BJ
Minerva Urol Nefrol; 2005 Sep; 57(3):175-97. PubMed ID: 15986016
[TBL] [Abstract][Full Text] [Related]
24. Management of hepatitis C in HIV infected and other immunocompromised individuals.
Seth AK
Trop Gastroenterol; 2006; 27(3):111-7. PubMed ID: 17310553
[TBL] [Abstract][Full Text] [Related]
25. Management of hepatitis C infection among patients with renal failure.
Latt NL; Araz F; Alachkar N; Durand CM; Gurakar A
Minerva Gastroenterol Dietol; 2015 Mar; 61(1):39-49. PubMed ID: 25390288
[TBL] [Abstract][Full Text] [Related]
26. Acute allograft rejection following interferon therapy for hepatitis C in recipients who have returned to dialysis after kidney transplant failure: case study.
Fabrizi F; D'Ambrosio R; Pallotti F; Berardinelli L; Messa P; Martin P; Aghemo A
Int J Artif Organs; 2014 Nov; 37(11):803-8. PubMed ID: 25362901
[TBL] [Abstract][Full Text] [Related]
27. Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C.
Mousa DH; Abdalla AH; Al-Shoail G; Al-Sulaiman MH; Al-Hawas FA; Al-Khader AA
Transplant Proc; 2004; 36(6):1831-4. PubMed ID: 15350490
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis C virus infection in haemodialysis and kidney transplant patients.
Baid-Agrawal S; Pascual M; Moradpour D; Frei U; Tolkoff-Rubin N
Rev Med Virol; 2008; 18(2):97-115. PubMed ID: 18064722
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis C treatment in patients with kidney disease.
Fabrizi F; Aghemo A; Messa P
Kidney Int; 2013 Nov; 84(5):874-9. PubMed ID: 23823603
[TBL] [Abstract][Full Text] [Related]
30. Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation.
Stravitz RT; Shiffman ML; Sanyal AJ; Luketic VA; Sterling RK; Heuman DM; Ashworth A; Mills AS; Contos M; Cotterell AH; Maluf D; Posner MP; Fisher RA
Liver Transpl; 2004 Jul; 10(7):850-8. PubMed ID: 15237368
[TBL] [Abstract][Full Text] [Related]
31. [Treatment of chronic hepatitis C virus infection in hemodialysis patients].
Kaya S
Mikrobiyol Bul; 2008 Jul; 42(3):525-34. PubMed ID: 18822900
[TBL] [Abstract][Full Text] [Related]
32. Successful treatment of donor-derived hepatitis C viral infection in three transplant recipients from a donor at increased risk for bloodborne pathogens.
Shah AP; Cameron A; Singh P; Frank AM; Fenkel JM
Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28060446
[TBL] [Abstract][Full Text] [Related]
33. Antiviral treatment with sofosbuvir and simeprevir in a kidney transplant recipient with HCV-decompensated cirrhosis: viral eradication and removal from the liver transplant waiting list.
Bonacci M; Londoño MC; Esforzado N; Forns X; Sotoca JM; Campistol JM
Transpl Int; 2015 Nov; 28(11):1345-9. PubMed ID: 26073850
[TBL] [Abstract][Full Text] [Related]
34. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
[TBL] [Abstract][Full Text] [Related]
35. Antiviral therapy of symptomatic HCV-mixed cryoglobulinemia after liver transplant: case report and literature review.
Francesca Donato M; Banfi G; Cresseri D; Battista Fogazzi G; Martin P; Messa P; Fabrizi F
Int J Artif Organs; 2013 May; 36(5):367-72. PubMed ID: 23446762
[TBL] [Abstract][Full Text] [Related]
36. Successful treatment of fibrosing cholestatic hepatitis after liver transplantation.
Cimsit B; Assis D; Caldwell C; Arvelakis A; Taddei T; Kulkarni S; Schilsky M; Emre S
Transplant Proc; 2011 Apr; 43(3):905-8. PubMed ID: 21486625
[TBL] [Abstract][Full Text] [Related]
37. Treatment of chronic hepatitis C in special groups.
Pol S; Zylberberg H; Fontaine H; Bréchot C
J Hepatol; 1999; 31 Suppl 1():205-9. PubMed ID: 10622589
[TBL] [Abstract][Full Text] [Related]
38. New approaches in the therapy of hepatitis C in dialysis patients.
Sikole A; Dzekova P; Asani A; Amitov V; Selim G; Gelev S; Polenakovic M
Prilozi; 2008 Dec; 29(2):155-64. PubMed ID: 19259044
[TBL] [Abstract][Full Text] [Related]
39. [Hepatitis C virus infection in hemodialysis].
Simon N
Pathol Biol (Paris); 1995 Oct; 43(8):735-40. PubMed ID: 8745596
[TBL] [Abstract][Full Text] [Related]
40. HCV and the kidney.
Corouge M; Vallet-Pichard A; Pol S
Liver Int; 2016 Jan; 36 Suppl 1():28-33. PubMed ID: 26725894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]